Most cases of basal cell carcinoma (BCC) are cured by surgery, but recurrent or disseminated disease does occur. Nonsurgical options are appropriate for patients with metastatic BCC and those with locally advanced disease considered inoperable or inappropriate for surgery. Recent exploration has begun to elucidate the pathogenesis of BCC, and clinical studies have assessed differences in subtypes and disease course, promoting investigation into a variety of novel nonsurgical therapies.

After completing this activity, participants should be better able to:

• Explain the importance of histology and risk factors in determining patient outcomes.

The educational design of this activity addresses the needs of dermatologists, dermatologic surgeons, medical oncologists, and other healthcare providers involved in the treatment of patients with basal cell carcinoma.

Click here to register.

ACCREDITATION and DESIGNATION STATEMENTS